Anaplastic oligodendrogliomas (AOs) are central nervous system (CNS) World Health Organization (WHO) grade 3 gliomas characterized by isocitrate dehydrogenase mutations (mIDHs) and 1p/19q codeletion [1,2]. The gene discussed is IDH3A; the disease is anaplastic oligodendroglioma.